Prevalence of Helicobacter pylori Resistance to Metronidazole, Clarithromycin, Amoxicillin, Tetracycline, and Furazolidone in Brazil

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Helicobacter

• Publication date

  2000-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1046/j.1523-5378.2000.00011.xPMID 10849055
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Furazolidone‐containing short‐term triple therapies are effective in the treatment of Helicobacter pylori infection

  1999cited by this paper
• Helicobacter pylori resists arrest

  1999cited by this paper
• Helicobacter pylori resists arrest

  1999cited by this paper
• High cure rate of Helicobacter pylori infection using tripotassium dicitrato bismuthate, furazolidone and clarithromycin triple therapy for 1 week

  1999cited by this paper
• Prevalence of Helicobacter pylori resistance to metronidazole, clarithromycin, amoxycillin, tetracycline and trovafloxacin in The Netherlands.

  1999cited by this paper
• Antibiotic resistance in Helicobacter pylori: implications for therapy.

  1998cited by this paper
• Addition of bismuth subnitrate to omeprazole plus amoxycillin improves eradication of Helicobacter pylori.

  1998cited by this paper
• Antibiotic resistance in Helicobacter pylori : Implications for therapy

  1998cited by this paper
• Acid suppression with ranitidine plus oral triple therapy improves ulcer healing but not Helicobacter pylori eradication.

  1998cited by this paper
• Amoxycillin resistance is one reason for failure of amoxycillin–omeprazole treatment of Helicobacter pylori infection

  1998cited by this paper
• Antibiotic resistance in Helicobacter pylori infection.

  1998cited by this paper
• Stable amoxicillin resistance in Helicobacter pylori.

  1998cited by this paper
• Addition of bismuth subnitrate to omeprazole plus amoxycillin improves eradication of Helicobacter pylori

  1998cited by this paper
• What other regimens are under investigation to treat Helicobacter pylori infection?

  1997cited by this paper
• Antimicrobial susceptibility testing of 230 Helicobacter pylori strains: importance of medium, inoculum, and incubation time

  1997cited by this paper
• Susceptibility of Helicobacter pylori Isolates against Agents Commonly Administered for Eradication Therapy and the Efficacy of Chemotherapy

  1997cited by this paper
• Who should be treated for Helicobacter pylori infection? A review of consensus conferences and guidelines.

  1997cited by this paper
• Terapeutica e epidemiologia da infeccao por "H. pylori": recomendacoes do primeiro seminario promovido pelo Nucleo Brasileiro para o Estudo do "Helicobacter pylori"

  1997cited by this paper
• How is Helicobacter pylori transmitted?

  1997cited by this paper
• Resistance of Helicobacter pylori to antibiotics

  1997cited by this paper
• Can therapy even be denied for Helicobacter pylori infection?

  1997cited by this paper
• In-vitro susceptibility of Helicobacter pylori to ampicillin, clarithromycin, metronidazole and omeprazole.

  1997cited by this paper
• Eradication of Helicobacter pylori: an objective assessment of current therapies.

  1997cited by this paper
• Editorial: Can Therapy Ever Be Denied for Helicobacter pylori Infection?

  1997cited by this paper
• The report of the Digestive Health InitiativeSM International Update Conference on Helicobacter pylori.

  1997cited by this paper
• Helicobacter pylori resistance to tetracycline.

  1996cited by this paper
• Clarithromycin resistance in Helicobacter pylori: prevalence in untreated dyspeptic patients and stability in vitro.

  1996cited by this paper
• Antimicrobial resistance and Helicobacter pylori.

  1996cited by this paper
• NIH Consensus Conference. Helicobacter pylori in peptic ulcer disease. NIH Consensus Development Panel on Helicobacter pylori in Peptic Ulcer Disease.

  1994cited by this paper
• Triple therapy with sucralfate is not effective in eradicating Helicobacter pylori and does not reduce duodenal ulcer relapse rates.

  1994cited by this paper
• Metronidazole-resistant Helicobacter pylori in a developing country.

  1993cited by this paper
• Duodenal ulcer and eradication of Helicobacter pylori in a developing country. An 18-month follow-up study.

  1992cited by this paper

• Inhibitory efficiency of various natural and synthetic antibacterial agents against bacteria isolated from a hospital environment

  2025cites this paper
• Furazolidone susceptibility of Helicobacter pylori isolated from patients with gastroduodenal diseases in Colombia

  2025influential citation
• Epidemiological study of antibiotic-resistant Helicobacter pylori in Brazil a meta-analysis

  2024cites this paper
• A Comprehensive Study to Identify Major Metabolites of an Amoxicillin–Sulbactam Hybrid Molecule in Rats and Its Metabolic Pathway Using UPLC-Q-TOF-MS/MS

  2022cites this paper
• Efflux Pump Mediated Antibiotic Resistance in Clinical Isolates of Helicobacter Pylori From South West Nigeria

  2020cites this paper
• Comparison between the two drug regimens of PPI+Amoxicillin+ Rifampicin and PPI+Amoxicillin+ Levofloxacin for the treatment of H. pylori infections resistant to the first line drug regimen among patients referred to Ilam clinics

  2019cites this paper
• Real-time PCR detection of a 16S rRNA single mutation of Helicobacter pylori isolates associated with reduced susceptibility and resistance to tetracycline in the gastroesophageal mucosa of individual hosts.

  2019cites this paper
• Resistance to Amoxicillin and Clarithromycin in Helicobacter pylori isolates in a tertiary care hospital

  2019cites this paper
• Clarithromycin-Susceptible But Virulent Helicobacter pylori Strains Infecting Iranian Patients’ Stomachs

  2019cites this paper
• N-Arylations of trifluoromethylated N-acylhydrazones with diaryliodonium salts as arylation reagents.

  2019cites this paper
• Oral pH sensitive GNS@ab nanoprobes for targeted therapy of Helicobacter pylori without disturbance gut microbiome.

  2019cites this paper
• Broad spectrum resistance in Helicobacter pylori isolated from gastric biopsies of patients with dyspepsia in Cameroon and efflux-mediated multiresistance detection in MDR isolates

  2019cites this paper
• Surveillance of the Antimicrobial Resistance Rates of Helicobacter pylori Ten Years Later in the Western Central Region, Colombia

  2019cites this paper
• Synthesis of carbohydrazides and carboxamides as anti-tubercular agents.

  2018cites this paper
• Antimicrobial activity of ellagic acid against Helicobacter pylori isolates from India and during infections in mice

  2018cites this paper
• Investigation of the Potential Resistance of the Bacteria Isolated from the Hospital Environment to Some Disinfectants and Antiseptcs

  2018cites this paper
• Efficacy and Tolerability of Two Quadruple Regimens: Bismuth, Omeprazole, Metronidazole with Amoxicillin or Tetracycline as First-Line Treatment for Eradication of Helicobacter Pylori in Patients with Duodenal Ulcer: A Randomized Clinical Trial

  2018cites this paper
• Resistance of Helicobacter pylori to furazolidone and levofloxacin: A viewpoint

  2017cites this paper
• Prevalence of Helicobacter Pylori infection among HIV-1 infected patients using Stool Antigen Tests in Jos, North-Central, Nigeria

  2016cites this paper
• Signal Detection of Adverse Drug Reaction of Amoxicillin Using the Korea Adverse Event Reporting System Database

  2016cites this paper
• Efficacy of levofloxacin, amoxicillin and a proton pump inhibitor in the eradication of Helicobacter pylori in Brazilian patients with peptic ulcers

  2015cites this paper
• Standard Triple Therapy versus Sequential Therapy in Helicobacter pylori Eradication: A Double-Blind, Randomized, and Controlled Trial

  2015cites this paper
• Meta-analysis: is combination of tetracycline and amoxicillin suitable for Helicobacter pylori infection?

  2015cites this paper
• Antibiotic resistance in Helicobacter pylori: Recent insights

  2014cites this paper
• Determinación in vitro de la resistencia de Helicobacter pylori a la furazolidona

  2014cites this paper
• Treatment of Helicobacter pylori infection: current status and future concepts.

  2014cites this paper
• Antimicrobial susceptibility testing for Helicobacter pylori isolates from Brazilian children and adolescents: Comparing agar dilution, E-test, and disk diffusion

  2014cites this paper
• Antibiotic Resistance of Helicobacter pylori in Latin America and the Caribbean

  2014cites this paper
• Emerging antimicrobial resistance pattern of Helicobacter pylori in central Gujarat.

  2014cites this paper
• RESISTANCE TO AMOXICILLIN, CLARITHROMYCIN AND CIPROFLOXACIN OF Helicobacter pylori ISOLATED FROM SOUTHERN BRAZIL PATIENTS

  2014cites this paper
• Resistencia antibiótica del Helicobacter pylori en América Latina y el Caribe Antibiotic Resistance of Helicobacter pylori in Latin America and the Caribbean

  2014cites this paper
• Determination of Antibiotic Resistance and Synergistic Effect of Multiple Antibiotics on Helicobacter Pylori Isolated from the Stomach Ulcer Biopsy Specimens

  2013cites this paper
• High Helicobacter pylori Resistance to Metronidazole and Clarithromycin in Brazilian Children and Adolescents

  2013cites this paper
• Low Helicobacter pylori primary resistance to clarithromycin in gastric biopsy specimens from dyspeptic patients of a city in the interior of São Paulo, Brazil

  2013cites this paper
• Association of a probiotic to a Helicobacter pylori eradication regimen does not increase efficacy or decreases the adverse effects of the treatment: a prospective, randomized, double-blind, placebo-controlled study

  2013cites this paper
• RELATIONSHIP BETWEEN DRUG RESISTANCE AND CAGA GENE IN HELICOBACTER PYLORI

  2013cites this paper
• Substitutions in Penicillin-Binding Protein 1 in Amoxicillin-Resistant Helicobacter pylori Strains Isolated from Korean Patients

  2013cites this paper
• Resistance pattern of Helicobacter pylori strains to clarithromycin, metronidazole, and amoxicillin in Isfahan, Iran

  2013cites this paper
• Determination of Antibiotic Sensitivity Pattern of Helicobacter pylori Isolates from South India Population by Epsilometer Test (E-Test)

  2012cites this paper
• Helicobacter pylori eradication in Western Australia using novel quadruple therapy combinations

  2012cites this paper
• Determination of Antibiotic Sensitivity Pattern of Helicobacter pylori Isolates from South India Population

  2012cites this paper
• Anti-Helicobacter pylori Potential of Artemisinin and Its Derivatives

  2012cites this paper
• Recent Insights into Antibiotic Resistance in Helicobacter pylori Eradication

  2012cites this paper
• Absence of Helicobacter pylori high tetracycline resistant 16S rDNA AGA926-928TTC genotype in gastric biopsy specimens from dyspeptic patients of a city in the interior of São Paulo, Brazil

  2012cites this paper
• Artemisinin and Its Derivatives Anti-Helicobacter pylori Potential of

  2012cites this paper
• CARACTERIZAÇÃO MOLECULAR DE GENES DE VIRULÊNCIA DE ISOLADOS CLÍNICOS DE Helicobacter pylori E DETERMINAÇÃO DA ATIVIDADE ANTIMICROBIANA IN VITRO DE DIFERENTES FITOTERÁPICOS UTILIZADOS NA MEDICINA POPULAR BRASILEIRA

  2012cites this paper
• DETERMINAÇÃO DA ATIVIDADE ANTIMICROBIANA in vitro DE EXTRATOS, FRAÇÕES E COMPOSTOS ISOLADOS DE Arrabidaea brachypoda

  2012cites this paper
• Application of Real‐Time PCR Stool Assay for Helicobacter pylori Detection and Clarithromycin Susceptibility Testing in Brazilian Children

  2011cites this paper
• Furazolidone as an Important Drug for Helicobacter Pylori Eradication

  2011cites this paper
• In vitro activity of bioactive compounds of selected South African medicinal plants on clinical isolates of Helicobacter pylori

  2011cites this paper
• Antimicrobial Activity of Northwestern Mexican Plants Against Helicobacter pylori

  2011cites this paper
• Helicobacter pylori antibiotic resistance in Brazil: clarithromycin is still a good option.

  2011cites this paper
• Comparison of the efficacy of triple versus quadruple therapy on the eradication of Helicobacter pylori and antibiotic resistance

  2010cites this paper
• High Prevalence of Clarithromycin Resistance and cagA, vacA, iceA2, and babA2 Genotypes of Helicobacter pylori in Brazilian Children

  2010cites this paper
• Helicobacter pylori eradication therapy.

  2010cites this paper
• Helicobacter pylori Reinfection in Brazilian Patients with Peptic Ulcer Disease: A 5‐Year Follow‐Up

  2010cites this paper
• Clarithromycin-based triple therapy for Helicobacter pylori treatment in peptic ulcer patients.

  2010cites this paper
• Tetracycline resistance in Chilean clinical isolates of Helicobacter pylori.

  2010cites this paper
• A comparison of 5 or 7 days of rabeprazole triple therapy for eradication of Helicobacter pylori

  2010cites this paper
• HELICOBACTER PYLORI RESISTANCE TO METRONIDAZOLE AND CLARITHROMYCIN IN DYSPEPTIC PATIENTS IN IRAN

  2010cites this paper
• Increase in resistance rates of H. pylori isolates to metronidazole and tetracycline--comparison of three 3-year studies.

  2010cites this paper
• Sequential Metronidazole‐Furazolidone or Clarithromycin‐Furazolidone Compared to Clarithromycin‐Based Quadruple Regimens for the Eradication of Helicobacter pylori in Peptic Ulcer Disease: A Double‐Blind Randomized Controlled Trial

  2010cites this paper
• Change in Antibiotic Resistance of Helicobacter pylori Strains and the Effect of A2143G Point Mutation of 23S rRNA on the Eradication of H. pylori in a Single Center of Korea

  2010cites this paper
• Short-Duration Furazolidone Therapy in Combination with Amoxicillin, Bismuth Subcitrate, and Omeprazole for Eradication of Helicobacter pylori

  2010cites this paper
• Anti-Helicobacter pylori activity of plant extracts traditionally used for the treatment of gastrointestinal disorders

  2010cites this paper
• Effect of resveratrol on Helicobacter pylori-induced interleukin-8 secretion, reactive oxygen species generation and morphological changes in human gastric epithelial cells.

  2009cites this paper
• Efficacy of a 7-day course of furazolidone, levofloxacin, and lansoprazole after failed Helicobacter pylori eradication

  2009cites this paper
• The role of active efflux in antibiotic - resistance of clinical isolates of Helicobacter pylori.

  2009cites this paper
• Proton motive force-dependent efflux of tetracycline in clinical isolates of Helicobacter pylori.

  2009cites this paper
• Furazolidone, Co-amoxiclav, Colloidal Bismuth Subcitrate, and Esomeprazole for Patients Who Failed to Eradicate Helicobacter pylori with Triple Therapy

  2009cites this paper
• Amoxicillin resistance with β‐lactamase production in Helicobacter pylori

  2009cites this paper
• Antimicrobial Susceptibility and Mutations Involved in Clarithromycin Resistance in Helicobacter pylori Isolates from Patients in the Western Central Region of Colombia

  2009cites this paper
• [Antimicrobial susceptibility of Helicobacter pylori strains isolated in Colombia].

  2009cites this paper
• Potent bactericidal constituents from Mallotus philippinensis against clarithromycin and metronidazole resistant strains of Japanese and Pakistani Helicobacter pylori.

  2009cites this paper
• Antimicrobial Resistance in Helicobacter and Campylobacter

  2009cites this paper
• Reinfecção pelo Helicobacter pylori em pacientes brasileiros com úlcera péptica, em seguimento de 5 anos

  2009cites this paper
• Who's Winning the War? Molecular Mechanisms of Antibiotic Resistance in Helicobacter pylori.

  2008cites this paper
• Quadruple therapy with furazolidone for retreatment in patients with peptic ulcer disease.

  2008cites this paper
• Helicobacter pylori infection in Children: clinical features and treatment of infection in children and adolescents

  2008cites this paper
• Helicobacter pylori amoxicillin heteroresistance due to point mutations in PBP-1A in isogenic isolates.

  2008cites this paper
• Short-term triple therapy with azithromycin for Helicobacter pylori eradication: Low cost, high compliance, but low efficacy

  2008cites this paper
• Clarithromycin- and omeprazole-containing gliadin nanoparticles for the treatment of Helicobacter pylori

  2008cites this paper
• Clarithromycin- and omeprazole-containing gliadin nanoparticles for the treatment of Helicobacter pylori.

  2008cites this paper
• Treatment of Helicobacter pylori infection. A survey in a group of generalists medical and specialists in Colombia

  2007cites this paper
• Análise das impressões digitais de DNA e de fatores de virulência de linhagens de Helicobacter pylori

  2007cites this paper
• Tratamiento de la infección por Helicobacter pylori. Encuesta en un grupo de médicos generales y especialistas en Colombia

  2007cites this paper
• Nitrofuran‐based regimens for the eradication of Helicobacter pylori infection

  2007cites this paper
• [Prevalence of metronidazole, clarithromycin and tetracycline resistance in Helicobacter pylori isolated from Chilean patients].

  2007cites this paper
• Helicobacter pylori primary resistant strains over 11 years in French children.

  2007cites this paper
• Quantitative real-time PCR for the clinical detection of Helicobacter pylori

  2007cites this paper
• Effect of Helicobacter pylori infection and acid blockade by lansoprazole on clarithromycin bioavailability.

  2007cites this paper
• [Analysis of molecular fingerprint and virulence factors of Helicobacter pylori strains].

  2007cites this paper
• Virulence factors and drug resistance in Escherichia coli isolated from extraintestinal infections.

  2007cites this paper
• EFFECT OF ONE WEEK FURAZOLIDONE IN COMBINATION WITH AMOXICILLIN, BISMUTH SUBCITRATE AND OMPERAZOLE ON ERADICATION OF HELICOBACTER PYLORI

  2007cites this paper
• Differentially expressed genes in response to amoxicillin in Helicobacter pylori analyzed by RNA arbitrarily primed PCR.

  2007cites this paper
• Correlation between Substitutions in Penicillin‐Binding Protein 1 and Amoxicillin Resistance in Helicobacter pylori

  2007cites this paper
• Oxidative stress expression status associated to Helicobacter pylori virulence in gastric diseases.

  2007cites this paper
• In Vitro Activity of a Novel Antimicrobial Agent, TG44, for Treatment of Helicobacter pylori Infection

  2006cites this paper
• Antibiotic Susceptibility of Helicobacter pylori Clinical Isolates: Comparative Evaluation of Disk-Diffusion and E-Test Methods

  2006cites this paper
• Triple, standard quadruple and ampicillin-sulbactam-based quadruple therapies for H. pylori eradication: a comparative three-armed randomized clinical trial.

  2006cites this paper